Frankfurt:L7R

Lipidor's subsidiary Emollivet takes the next step towards launch and receives funding from Vinnova

STOCKHOLM, April 23, 2021 /PRNewswire/ -- Sweden's innovation authority Vinnova is investing in Lipidor's subsidiary Emollivet. The funding from Vinnova is for SEK 300,000 and will be used for a project in which Emollivet, through interaction with animal owners and others in the animal health mark...

2021-04-23 15:22 1808

Lipidor announces positive outcome of feasibility study for development of topical medical cannabis products based on the company's AKVANO® technology

STOCKHOLM, Sept. 30, 2020 /PRNewswire/ -- Lipidor AB (Nasdaq First North:LIPI)  today announces a positive outcome of the feasibility study into the development of topical medicinal cannabis products for the treatment of skin inflammations and psoriatic lesions. The study was conducted in collabor...

2020-09-30 15:44 3050